In the SOX4-expressing components of the tumor, a subset of cells with higher nuclear β-catenin levels and cholangiocytic markers express FGF19, which promotes proliferation of surrounding HNF4A-expressing hepatoblastic cells (Fig. 8k). Here, FGF19 is linked to neoplasm.